| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a99494c50d8e3062d596d8db9f299f8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2002-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4271b37431ce96ce99bc7bbd5e5502c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8023cb7ca668cc4069e9f8f248a2fc27 |
| publicationDate |
2003-06-19^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2469923-A1 |
| titleOfInvention |
Biallelic markers of d-amino acid oxidase and uses thereof |
| abstract |
The invention concerns the human DAO gene, polynucleotides, and biallelic markers. The invention also concerns the association established between schizophrenia and the biallelic markers. The invention provides means to determine the predisposition of individuals to schizophrenia or related CNS disorder, as well as means for the disease diagnosis and prognosis. |
| priorityDate |
2001-12-12^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |